A citation-based method for searching scientific literature

Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
Times Cited: 817







List of co-cited articles
967 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Erina Joo, Norio Harada, Shunsuke Yamane, Toru Fukushima, Daisuke Taura, Kanako Iwasaki, Akiko Sankoda, Kimitaka Shibue, Takanari Harada, Kazuyo Suzuki,[...]. Diabetes 2017
48
8

Intra-islet glucagon signaling is critical for maintaining glucose homeostasis.
Lu Zhu, Diptadip Dattaroy, Jonathan Pham, Lingdi Wang, Luiz F Barella, Yinghong Cui, Kenneth J Wilkins, Bryan L Roth, Ute Hochgeschwender, Franz M Matschinsky,[...]. JCI Insight 2019
70
5

Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
Shu Chen, Fumiaki Okahara, Noriko Osaki, Akira Shimotoyodome. Am J Physiol Endocrinol Metab 2015
42
9

Gut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice.
Youngmi Song, Jacqueline A Koehler, Laurie L Baggio, Alvin C Powers, Darleen A Sandoval, Daniel J Drucker. Cell Metab 2019
52
7

Preproglucagon neurons project widely to autonomic control areas in the mouse brain.
I J Llewellyn-Smith, F Reimann, F M Gribble, S Trapp. Neuroscience 2011
126
4

Mechanisms to Elevate Endogenous GLP-1 Beyond Injectable GLP-1 Analogs and Metabolic Surgery.
Daniel A Briere, Ana B Bueno, Ellen J Gunn, M Dodson Michael, Kyle W Sloop. Diabetes 2018
34
11

Central and peripheral GLP-1 systems independently suppress eating.
Daniel I Brierley, Marie K Holt, Arashdeep Singh, Alan de Araujo, Molly McDougle, Macarena Vergara, Majd H Afaghani, Shin Jae Lee, Karen Scott, Calyn Maske,[...]. Nat Metab 2021
47
8

Genetic Identification of Vagal Sensory Neurons That Control Feeding.
Ling Bai, Sheyda Mesgarzadeh, Karthik S Ramesh, Erica L Huey, Yin Liu, Lindsay A Gray, Tara J Aitken, Yiming Chen, Lisa R Beutler, Jamie S Ahn,[...]. Cell 2019
150
4

Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.
C F Deacon, L Pridal, L Klarskov, M Olesen, J J Holst. Am J Physiol 1996
255
4

Gut chemosensing mechanisms.
Arianna Psichas, Frank Reimann, Fiona M Gribble. J Clin Invest 2015
145
4

The Discovery and Development of Liraglutide and Semaglutide.
Lotte Bjerre Knudsen, Jesper Lau. Front Endocrinol (Lausanne) 2019
191
4

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans.
Akila De Silva, Victoria Salem, Christopher J Long, Aidan Makwana, Rexford D Newbould, Eugenii A Rabiner, Mohammad A Ghatei, Stephen R Bloom, Paul M Matthews, John D Beaver,[...]. Cell Metab 2011
209
4


Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
Stephanie Sisley, Ruth Gutierrez-Aguilar, Michael Scott, David A D'Alessio, Darleen A Sandoval, Randy J Seeley. J Clin Invest 2014
224
4


Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice.
M Nagashima, T Watanabe, M Terasaki, M Tomoyasu, K Nohtomi, J Kim-Kaneyama, A Miyazaki, T Hirano. Diabetologia 2011
167
4

Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher. Neuropharmacology 2016
51
7

Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point.
Rayner Rodriguez-Diaz, R Damaris Molano, Jonathan R Weitz, Midhat H Abdulreda, Dora M Berman, Barbara Leibiger, Ingo B Leibiger, Norma S Kenyon, Camillo Ricordi, Antonello Pileggi,[...]. Cell Metab 2018
96
4


The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice.
Adam P Chambers, Joyce E Sorrell, April Haller, Karen Roelofs, Chelsea R Hutch, Ki-Suk Kim, Ruth Gutierrez-Aguilar, Bailing Li, Daniel J Drucker, David A D'Alessio,[...]. Cell Metab 2017
133
4


Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease.
Dilan Athauda, Thomas Foltynie. Neuropharmacology 2018
52
7


Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Grazia Daniela Femminella, Eleni Frangou, Sharon B Love, Gail Busza, Clive Holmes, Craig Ritchie, Robert Lawrence, Brady McFarlane, George Tadros, Basil H Ridha,[...]. Trials 2019
71
5



The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem.
Elvira Alvarez, M Dolores Martínez, Isabel Roncero, Julie A Chowen, Beatriz García-Cuartero, Juan D Gispert, Carmen Sanz, Patricia Vázquez, Antonio Maldonado, Javier de Cáceres,[...]. J Neurochem 2005
177
4

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
967
4

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
4



GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
405
4

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Therese S Salameh, Elizabeth M Rhea, Konrad Talbot, William A Banks. Biochem Pharmacol 2020
21
19

Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis.
Yazhou Li, Srinivasulu Chigurupati, Harold W Holloway, Mohamed Mughal, David Tweedie, Daniel A Bruestle, Mark P Mattson, Yun Wang, Brandon K Harvey, Balmiki Ray,[...]. PLoS One 2012
83
4


The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Henrik H Hansen, Pernille Barkholt, Katrine Fabricius, Jacob Jelsing, Dick Terwel, Charles Pyke, Lotte Bjerre Knudsen, Niels Vrang. Brain Res 2016
50
8

Unimolecular Polypharmacy for Treatment of Diabetes and Obesity.
Matthias H Tschöp, Brian Finan, Christoffer Clemmensen, Vasily Gelfanov, Diego Perez-Tilve, Timo D Müller, Richard D DiMarchi. Cell Metab 2016
147
4

Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.
Melissa K Thomas, Amir Nikooienejad, Ross Bray, Xuewei Cui, Jonathan Wilson, Kevin Duffin, Zvonko Milicevic, Axel Haupt, Deborah A Robins. J Clin Endocrinol Metab 2021
43
9

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
589
4

Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Robert E Steinert, Christine Feinle-Bisset, Lori Asarian, Michael Horowitz, Christoph Beglinger, Nori Geary. Physiol Rev 2017
268
4



Drug Therapy in Obesity: A Review of Current and Emerging Treatments.
David M Williams, Asif Nawaz, Marc Evans. Diabetes Ther 2020
58
6

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
Melanie Davies, Louise Færch, Ole K Jeppesen, Arash Pakseresht, Sue D Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A Wadden,[...]. Lancet 2021
109
4


Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Stefano Del Prato, Steven E Kahn, Imre Pavo, Govinda J Weerakkody, Zhengyu Yang, John Doupis, Diego Aizenberg, Alan G Wynne, Jeffrey S Riesmeyer, Robert J Heine,[...]. Lancet 2021
33
12

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Thomas A Wadden, Timothy S Bailey, Liana K Billings, Melanie Davies, Juan P Frias, Anna Koroleva, Ildiko Lingvay, Patrick M O'Neil, Domenica M Rubino, Dorthe Skovgaard,[...]. JAMA 2021
117
4

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Paul Angulo, David E Kleiner, Sanne Dam-Larsen, Leon A Adams, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills, Jill C Keach, Heather D Lafferty, Alisha Stahler,[...]. Gastroenterology 2015
3

An obesity-associated gut microbiome with increased capacity for energy harvest.
Peter J Turnbaugh, Ruth E Ley, Michael A Mahowald, Vincent Magrini, Elaine R Mardis, Jeffrey I Gordon. Nature 2006
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.